215 related articles for article (PubMed ID: 31373033)
1. C/EBPα mediates the growth inhibitory effect of progestins on breast cancer cells.
Nacht AS; Ferrari R; Zaurin R; Scabia V; Carbonell-Caballero J; Le Dily F; Quilez J; Leopoldi A; Brisken C; Beato M; Vicent GP
EMBO J; 2019 Sep; 38(18):e101426. PubMed ID: 31373033
[TBL] [Abstract][Full Text] [Related]
2. Methylation of C/EBPα by PRMT1 Inhibits Its Tumor-Suppressive Function in Breast Cancer.
Liu LM; Sun WZ; Fan XZ; Xu YL; Cheng MB; Zhang Y
Cancer Res; 2019 Jun; 79(11):2865-2877. PubMed ID: 31015230
[TBL] [Abstract][Full Text] [Related]
3. FGF2 induces breast cancer growth through ligand-independent activation and recruitment of ERα and PRBΔ4 isoform to MYC regulatory sequences.
Giulianelli S; Riggio M; Guillardoy T; Pérez Piñero C; Gorostiaga MA; Sequeira G; Pataccini G; Abascal MF; Toledo MF; Jacobsen BM; Guerreiro AC; Barros A; Novaro V; Monteiro FL; Amado F; Gass H; Abba M; Helguero LA; Lanari C
Int J Cancer; 2019 Oct; 145(7):1874-1888. PubMed ID: 30843188
[TBL] [Abstract][Full Text] [Related]
4. Activation of mitogen- and stress-activated kinase 1 is required for proliferation of breast cancer cells in response to estrogens or progestins.
Reyes D; Ballaré C; Castellano G; Soronellas D; Bagó JR; Blanco J; Beato M
Oncogene; 2014 Mar; 33(12):1570-80. PubMed ID: 23604116
[TBL] [Abstract][Full Text] [Related]
5. A set of accessible enhancers enables the initial response of breast cancer cells to physiological progestin concentrations.
Zaurin R; Ferrari R; Nacht AS; Carbonell J; Le Dily F; Font-Mateu J; de Llobet Cucalon LI; Vidal E; Lioutas A; Beato M; Vicent GP
Nucleic Acids Res; 2021 Dec; 49(22):12716-12731. PubMed ID: 34850111
[TBL] [Abstract][Full Text] [Related]
6. Progesterone induction of the 11beta-hydroxysteroid dehydrogenase type 2 promoter in breast cancer cells involves coordinated recruitment of STAT5A and progesterone receptor to a distal enhancer and polymerase tracking.
Subtil-Rodríguez A; Millán-Ariño L; Quiles I; Ballaré C; Beato M; Jordan A
Mol Cell Biol; 2008 Jun; 28(11):3830-49. PubMed ID: 18378698
[TBL] [Abstract][Full Text] [Related]
7. Expression of the CCAAT/enhancer-binding proteins C/EBPalpha, C/EBPbeta and C/EBPdelta in breast cancer: correlations with clinicopathologic parameters and cell-cycle regulatory proteins.
Milde-Langosch K; Löning T; Bamberger AM
Breast Cancer Res Treat; 2003 May; 79(2):175-85. PubMed ID: 12825852
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of the G protein-coupled receptor kinase 6 (GRK6) promoter inhibits binding of C/EBPα, and GRK6 knockdown promotes cell migration and invasion in lung adenocarcinoma cells.
Yao S; Wu D; Chen J; Wang P; Lv X; Huang J
FEBS Open Bio; 2019 Apr; 9(4):605-617. PubMed ID: 30984536
[TBL] [Abstract][Full Text] [Related]
9. C/EBPα inhibits proliferation of breast cancer cells via a novel pathway of miR-134/CREB.
Zhang J; Ma Y; Wang S; Chen F; Gu Y
Int J Clin Exp Pathol; 2015; 8(11):14472-8. PubMed ID: 26823765
[TBL] [Abstract][Full Text] [Related]
10. RNPC1 enhances progesterone receptor functions by regulating its mRNA stability in breast cancer.
Lou P; Li C; Shi L; Xia TS; Zhou W; Wu J; Zhou X; Li X; Wang Y; Wei JF; Ding Q
Oncotarget; 2017 Mar; 8(10):16387-16400. PubMed ID: 27634883
[TBL] [Abstract][Full Text] [Related]
11. miR-381 suppresses C/EBPα-dependent Cx43 expression in breast cancer cells.
Ming J; Zhou Y; Du J; Fan S; Pan B; Wang Y; Fan L; Jiang J
Biosci Rep; 2015 Oct; 35(6):. PubMed ID: 26450928
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of C/EBPalpha in breast cancer cells by hypoxia-estrogen combination is mainly due to hypoxia.
Seifeddine R; Fulchignoni-Lataud MC; Massaad-Massade L
Anticancer Res; 2009 Apr; 29(4):1227-31. PubMed ID: 19414368
[TBL] [Abstract][Full Text] [Related]
13. Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells.
Shackleford TJ; Zhang Q; Tian L; Vu TT; Korapati AL; Baumgartner AM; Le XF; Liao WS; Claret FX
Breast Cancer Res; 2011 Jun; 13(3):R65. PubMed ID: 21689417
[TBL] [Abstract][Full Text] [Related]
14. Protein kinases mediate ligand-independent derepression of sumoylated progesterone receptors in breast cancer cells.
Daniel AR; Lange CA
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14287-92. PubMed ID: 19706513
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP
Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211
[TBL] [Abstract][Full Text] [Related]
16. Breast Cancer Suppression by Progesterone Receptors Is Mediated by Their Modulation of Estrogen Receptors and RNA Polymerase III.
Finlay-Schultz J; Gillen AE; Brechbuhl HM; Ivie JJ; Matthews SB; Jacobsen BM; Bentley DL; Kabos P; Sartorius CA
Cancer Res; 2017 Sep; 77(18):4934-4946. PubMed ID: 28729413
[TBL] [Abstract][Full Text] [Related]
17. CCAAT-enhancer binding protein-α (C/EBPα) and hepatocyte nuclear factor 4α (HNF4α) regulate expression of the human fructose-1,6-bisphosphatase 1 (FBP1) gene in human hepatocellular carcinoma HepG2 cells.
Wattanavanitchakorn S; Rojvirat P; Chavalit T; MacDonald MJ; Jitrapakdee S
PLoS One; 2018; 13(3):e0194252. PubMed ID: 29566023
[TBL] [Abstract][Full Text] [Related]
18. Multimodal regulation of E2F1 gene expression by progestins.
Wade HE; Kobayashi S; Eaton ML; Jansen MS; Lobenhofer EK; Lupien M; Geistlinger TR; Zhu W; Nevins JR; Brown M; Otteson DC; McDonnell DP
Mol Cell Biol; 2010 Apr; 30(8):1866-77. PubMed ID: 20123965
[TBL] [Abstract][Full Text] [Related]
19. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: I. "Loss of function" alterations in the c/EBPdelta growth inhibitory pathway in breast cancer cell lines.
Sivko GS; DeWille JW
J Cell Biochem; 2004 Nov; 93(4):830-43. PubMed ID: 15389879
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of Telapristone Acetate (CDB4124) on Progesterone Receptor Action in Breast Cancer Cells.
Davaadelger B; Murphy AR; Clare SE; Lee O; Khan SA; Kim JJ
Endocrinology; 2018 Oct; 159(10):3581-3595. PubMed ID: 30203004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
